B
IndiaDescription
India's largest biopharmaceutical company, headquartered in Electronic City, Bengaluru, and publicly listed. Four segments: generics — small-molecule APIs and formulations — biosimilars through Biocon Biologics, research services through Syngene, and novel biologics. Focus on diabetes, oncology and immunology. States twelve commercialised biologics and supply to more than 120 countries.